Alexa Fluor® 647 anti-Tau Phospho (Thr231) Antibody, Tau Phospho (Thr231), A23009A,BioLegend,683854

For use of this antibody in immunohistochemistry on FFPE tissues (IHC-P), we recommend Citrate buffer (Cat. No. 420902) for antigen retrieval.

Host

Mouse

Reactivity

Human, Rat

Application

IHC-P - Quality tested

Platform ID

BAB491409741

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameAlexa Fluor® 647 anti-Tau Phospho (Thr231) Antibody, Tau Phospho (Thr231), A23009A
Cat. No.683854
HostMouse
RRIDAB_3675195 (BioLegend Cat. No. 683853)AB_3675195 (BioLegend Cat. No. 683854)
IsotypeMouse IgG2b, κ
ReactivityHuman, Rat
ApplicationIHC-P - Quality tested
ClonalityMonoclonal
Clone NumberA23009A
Concentration0.5 mg/mL
TargetTau Phospho Thr231
ImmunogenSynthetic human Tau peptide phosphorylated at Thr231
PurityThe antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 647 under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

Paired helical filaments (PHFs) are the major building blocks of neurofibrillary lesions in Alzheimer's disease brains and are composed of hyperphosphorylated Tau protein. Predominantly expressed in axons, alternatively spliced forms of Tau comprise a family of microtubule-associated proteins that normally promote and stabilize the assembly of microtubules. PHF-Tau differs from normal Tau by its abnormal hyperphosphorylation, which results in decreased binding of Tau to microtubules. The decreased affinity of PHF-Tau for microtubules, coupled with reduced levels of normal Tau, destabilizes microtubules leading to an impairment of axonal transport, neuronal death and the aggregation of PHFs. Therefore, hyperphosphorylation of Tau is believed to be a key event in the pathogenesis of Alzheimer's disease.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.